Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 4 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean
xining xia
(174 results)?
Feedback activation of EGFR/wild-type RAS signaling axis limits KRASG12D inhibitor efficacy in KRASG12D-mutated colorectal cancer.
Oncogene. 2023 May;42(20):1620-1633. doi: 10.1038/s41388-023-02676-9. Epub 2023 Apr 5.
Oncogene. 2023.
PMID: 37020035
Free PMC article.
Targeting metabolic vulnerability in mitochondria conquers MEK inhibitor resistance in KRAS-mutant lung cancer.
Feng J, Lian Z, Xia X, Lu Y, Hu K, Zhang Y, Liu Y, Hu L, Yuan K, Sun Z, Pang X.
Feng J, et al. Among authors: xia x.
Acta Pharm Sin B. 2023 Mar;13(3):1145-1163. doi: 10.1016/j.apsb.2022.10.023. Epub 2022 Oct 28.
Acta Pharm Sin B. 2023.
PMID: 36970205
Free PMC article.
Item in Clipboard
Design, Synthesis, and Pharmacological Evaluation of Multisubstituted Pyrido[4,3-d]pyrimidine Analogues Bearing Deuterated Methylene Linkers as Potent KRASG12D Inhibitors.
Xiao X, Feng J, Ma J, Xia X, Liu X, Zhang J, Ding C, Pang X, Zhang A.
Xiao X, et al. Among authors: xia x.
J Med Chem. 2023 Nov 23;66(22):15524-15549. doi: 10.1021/acs.jmedchem.3c01724. Epub 2023 Nov 3.
J Med Chem. 2023.
PMID: 37921024
Item in Clipboard
Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance.
He P, Feng J, Xia X, Sun Y, He J, Guan T, Peng Y, Zhang X, Liu M, Pang X, Chen Y.
He P, et al. Among authors: xia x.
J Med Chem. 2023 May 11;66(9):6047-6069. doi: 10.1021/acs.jmedchem.2c01844. Epub 2023 May 2.
J Med Chem. 2023.
PMID: 37130350
Item in Clipboard
Cite
Cite